Zori R T, Schatz D A, Ostrer H, Williams C A, Spillar R, Riley W J
Department of Pediatrics, University of Florida, Gainesville 32610.
Am J Med Genet Suppl. 1990;7:238-41. doi: 10.1002/ajmg.1320370748.
The extent to which autoimmunity contributes to thyroid dysfunction in Down Syndrome (DS) individuals has not been clarified. We studied 61 persons (34 males and 27 females) with DS (age 5 months to 48 years) for the presence of thyroid autoantibodies (thyroid microsomal antibodies and thyroglobulin antibodies), pancreatic islet cell autoantibodies, gastric parietal cell autoantibodies, and adrenocortical autoantibodies. Thyroid function was determined by measurement of TSH. HLA-A, B and -DR typing was performed on 52 subjects. Forty of 61 subjects (66%) had thyroid dysfunction: elevated TSH values (greater than 5 mcIU/ml) were found in 35 of 61 individuals; 3 subjects had previously documented Hashimoto thyroiditis and were on therapy for hyperthyroidism; and 2 persons had Graves disease. No age or sex variation was detected. Seventeen (28%) subjects had thyroid autoantibodies. Fifteen of the 17 had thyroid dysfunction. Twelve of 25 subjects (48%) over 10 years with thyroid dysfunction had thyroid autoantibodies compared to only 3 of 15 (20%) under the age of 10 years. However, children less than of 10 years tended to have higher TSH values. Only 1 individual who had thyroid antibodies had gastric parietal cell autoantibodies present. Islet cell and adrenocortical autoantibodies were not found in any individuals. Neither thyroid dysfunction nor thyroid autoantibodies correlated with any HLA allele. These findings suggest that thyroid dysfunction in individuals with DS of all ages is a common heterogeneous disorder which cannot be solely explained on the basis of autoimmunity. We recommend that thyroid function be followed closely whether or not thyroid autoantibodies are present.
自身免疫在唐氏综合征(DS)患者甲状腺功能障碍中所起的作用程度尚未明确。我们研究了61例年龄在5个月至48岁之间的DS患者(34例男性和27例女性),检测他们是否存在甲状腺自身抗体(甲状腺微粒体抗体和甲状腺球蛋白抗体)、胰岛细胞自身抗体、胃壁细胞自身抗体和肾上腺皮质自身抗体。通过检测促甲状腺激素(TSH)来确定甲状腺功能。对52名受试者进行了HLA - A、B和 - DR分型。61名受试者中有40名(66%)存在甲状腺功能障碍:61名个体中有35名TSH值升高(大于5 mIU/ml);3名受试者之前已确诊为桥本甲状腺炎且正在接受甲亢治疗;2名患有格雷夫斯病。未检测到年龄或性别差异。17名(28%)受试者存在甲状腺自身抗体。这17名中有15名存在甲状腺功能障碍。25名年龄超过10岁且有甲状腺功能障碍的受试者中有12名(48%)存在甲状腺自身抗体,而15名年龄小于10岁的受试者中只有3名(20%)存在甲状腺自身抗体。然而,10岁以下儿童的TSH值往往更高。只有1名有甲状腺抗体的个体同时存在胃壁细胞自身抗体。在任何个体中均未发现胰岛细胞和肾上腺皮质自身抗体。甲状腺功能障碍和甲状腺自身抗体均与任何HLA等位基因无关。这些发现表明,各年龄段DS患者的甲状腺功能障碍是一种常见的异质性疾病,不能仅基于自身免疫来解释。我们建议无论是否存在甲状腺自身抗体,都应密切监测甲状腺功能。